Global Oncology Market

Oncology Market Size, Share, Growth Analysis, By Cancer Diagnostics & Treatment(Cancer Diagnostics {Tumor Biomarker Test, Imaging, Biopsy, Liquid Biopsy), By Cancer Type(Lung Cancer, Prostate Cancer, Colon & Rectal Cancer, Gastric Cancer), By End-Use(Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Academia), By Region - Industry Forecast 2024-2031


Report ID: SQSG35J2013 | Region: Global | Published Date: February, 2024
Pages: 157 |Tables: 103 |Figures: 76

Oncology Market Insights

Oncology Market size was valued at USD 286.04 billion in 2019 and is poised to grow from USD 309.3 billion in 2023 to USD 581.25 billion by 2031, growing at a CAGR of 8.2% in the forecast period (2024-2031).

Cancer is the world's third most fatal disease, following only cardiovascular, parasitic, and infectious disorders. Chemoprevention is described as pharmacological intervention with synthetic or naturally occurring chemicals that have the potential to inhibit or prevent carcinogenesis. Cancer treatment includes surgery, radiation, and medications. Surgery is the first line of treatment for cancer in its early stages. Radiotherapy is most commonly used in conjunction with surgical operations in a localized environment. Finally, medications are used in conjunction with chemotherapy (CTX), which employs a diverse set of agents having cytotoxic effects. Cancer treatment that targets the alterations in cancer cells that enable them grow, divide, and disseminate is known as targeted therapy. Rising alcohol and cigarette intake has resulted in an increase in the global oncology burden. Furthermore, since industry players place a high emphasis on developing novel medication candidates targeting various types of malignancies, the market is expected to increase steadily during the forecast period.

Market snapshot - 2024-2031

Global Market Size

USD 286.04 billion

Largest Segment

Cancer Treatment

Fastest Growth

Cancer Treatment

Growth Rate

8.2% CAGR

Global Oncology Market 2021-2028 ($ Mn)
Country Share for North America Region- 2021 (%)
Global Oncology Market Size by Cancer Diagnostics & Treatment, 2021-2028 ($ Mn)
Global Oncology Market Size by Cancer Diagnostics & Treatment, 2021-2028 (%)

To get more reports on the above market click here to Buy The Report

Oncology Market Segmental Analysis

The global oncology market is segmented based cancer diagnostics & treatment, cancer type, end-use, and region. Based on the cancer diagnostics & treatment, the market is segmented into cancer diagnostics {tumor biomarker test, imaging, biopsy, liquid biopsy, immunohistochemistry, in situ hybridization}, cancer treatment {chemotherapy, targeted therapy, immunotherapy, hormonal therapy}. Based on the cancer type, the market is segmented into lung cancer, prostate cancer, colon & rectal cancer, gastric cancer, esophageal cancer, liver cancer, breast cancer. Based on the end-use, the market is segmented into hospitals, diagnostic laboratories, diagnostic imaging centers, academia, specialty clinics. Based on the region, the market is categorized into North America, Europe, Asia-Pacific, South America, and MEA.

Oncology Market Analysis by Cancer Diagnostic and Treatment

Based on the cancer diagnostics & treatment, the market is segmented into cancer diagnostics {tumor biomarker test, imaging, biopsy, liquid biopsy, immunohistochemistry, in situ hybridization}, cancer treatment {chemotherapy, targeted therapy, immunotherapy, hormonal therapy}. Among these, the treatment segment is projected to hold the significant share in the global oncology market. The targeted therapy category dominated the global market. The increased usage and demand for targeted medications in emerging regions for the treatment of various malignancies is contributed to the segment's larger proportion. This is because of its capacity to target only malignant cells and treat advanced tumors like metastatic breast cancer.

The immunotherapy segment, on the other hand, is expected to increase at the fastest rate throughout the projection period. The segment's largest growth rate is attributable to the launch of numerous pharmaceuticals of this type by important market participants, as well as substantial research and development by research institutions. For example, in July 2020, Aichi Cancer Center and NEC Corporation announced the initiation of basic research aimed at advanced cancer immunotherapy via the merger of AI and immunology.

Global Oncology Market By Cancer Diagnostics & Treatment, 2021 (%), 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Oncology Market Regional Insights

In 2021, North America is expected to have the biggest share of the global oncology market. The region's dominance is due to the increased incidence and prevalence of cancer in the United States, as well as new product introductions in the region. According to the National Cancer Institute, roughly 1.8 million people in the United States will be diagnosed with cancer in 2020. Europe, after North America, is expected to account for the second-largest share of the global market. Because of the rising cancer burden, high-growth countries such as the United Kingdom, Germany, France, Italy, and Spain will contribute to the expansion of the European oncology market. Because of increased population awareness, the Asia Pacific oncology market is likely to grow at a quicker rate. The rising prevalence of cancer and rising healthcare costs will boost regional growth. Latin America, the Middle East, and Africa are projected to see sluggish development due to a lack of awareness and affordability of high-cost biologic medications.

Global Oncology Market By Geography, 2021 - 2028, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Oncology Market Dynamics

Oncology Market Driver

  • The oncology market growth is attributed to the rising prevalence of cancer across the globe. Cancer has become the second greatest cause of death in the world, trailing only cardiovascular disease. This is caused by factors such as cigarette use, changing dietary patterns, and an extended post-reproductive lifespan. Cancer, for example, is a growing burden, with the number of new cancer cases expected to rise from 18.1 million in 2018 to 29.4 million by 2040, according to the World Health Organization (WHO). As a result, the rising prevalence of cancer is predicted to drive demand for worldwide oncology cancer medications during the forecast period. Furthermore, increased cancer awareness among the people is expected to benefit the global market in the approaching years.

Oncology Market Restraint

  • Adverse drug effects, stringent regulations, and patent expiration will all limit the oncology market growth. Chemotherapy medications kill cancer cells while also causing harm to normal bodily cells. As a result, the patients experience a variety of negative effects. Bone marrow suppression, gastrointestinal disorders, neuropathies, hair loss, weariness, and skin diseases are among the most prevalent side effects. As a result, the adverse effects associated with oncology medications are having a detrimental impact on market growth. Furthermore, rigorous government regulations, high medicine costs, and patent expiration are some of the key factors impeding worldwide market progress throughout the projection period.

Request Free Customization of this report to help us to meet your business objectives.

Oncology Market Competitive Landscape

The oncology market is fragmented in nature. The prominent players operating in the market are constantly adopting various growth strategies in order to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D in order to supply industries with the most efficient and cost-effective solutions.

Oncology Market Top Company Profiles

  • Roche Holding AG
  • Novartis International AG
  • Bristol-Myers Squibb Company
  • Pfizer Inc.
  • Merck & Co., Inc.
  • AstraZeneca PLC
  • Johnson & Johnson
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited
  • Amgen Inc.
  • AbbVie Inc.
  • Eli Lilly and Company
  • Gilead Sciences, Inc.
  • Celgene Corporation (a subsidiary of Bristol-Myers Squibb Company)
  • Bayer AG
  • Biogen Inc.
  • Daiichi Sankyo Company, Limited
  • Astellas Pharma Inc.
  • Eisai Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.

Oncology Market Recent Developments

  • In July 2021, AstraZeneca announced that their medicine Imfinzi has been approved for the treatment of patients with non-small cell lung cancer by China's National Medical Products Administration.
  • In June 2021, Bayer AG has announced an agreement to buy Noria Therapeutics Inc. and PSMA Therapeutics Inc. Bayer will obtain exclusive rights to the company's experimental substance under this agreement. This acquisition will aid Bayer's cancer portfolio expansion.
  • In April 2021, Sanofi announced the acquisition of Tidal Therapeutics, a pre-clinical biotech firm developing an mRNA-based research platform. Sanofi will be able to use this new technology platform to expand their research capabilities in oncology, immunology, and other disease areas as a result of this acquisition.

Oncology Key Market Trends

  • The expansion of the oncology market is aided by the growing focus on R&D to increase adoption of advanced drug therapies. The goals of cancer treatment are to cure the disease, prolong survival, and improve quality of life. Immune cells are crucial in tumor growth. As a result, boosting immune responses to malignancies is an appealing therapeutic and preventative method. As a result, top market players are investing in immunotherapy research and development to treat various tumors. In March 2019, for example, FUJIFILM Corporation and the National Cancer Center Japan announced the start of a joint research effort for novel cancer immunotherapy employing a liposome formulation. Immunotherapy has a stronger market adoption due to its success in terms of efficient treatment, which results in better patient outcomes. As a result, this contributes to market growth.

Oncology Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.

According to our analysis, the global oncology market is segmented based cancer diagnostics & treatment, cancer type, end-use, and region. Based on the cancer diagnostics & treatment, the cancer treatment segment is projected to hold the substantial share. Based on the cancer type, the prostate cancer and breast cancer segments are projected to hold the substantial share. Based on the end-use, the hospitals segment is projected to hold the substantial share. Based on the region, the North America region is projected to hold the substantial share.

Report Metric Details
Market size value in 2023 USD 286.04 billion
Market size value in 2031 USD 581.25 billion
Growth Rate 8.2%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Cancer Diagnostics & Treatment
    • Cancer Diagnostics {Tumor Biomarker Test, Imaging, Biopsy, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization}, Cancer Treatment {Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy}
  • Cancer Type
    • Lung Cancer, Prostate Cancer, Colon & Rectal Cancer, Gastric Cancer, Esophageal Cancer, Liver Cancer, Breast Cancer
  • End-Use
    • Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Academia, Specialty Clinics
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Roche Holding AG
  • Novartis International AG
  • Bristol-Myers Squibb Company
  • Pfizer Inc.
  • Merck & Co., Inc.
  • AstraZeneca PLC
  • Johnson & Johnson
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited
  • Amgen Inc.
  • AbbVie Inc.
  • Eli Lilly and Company
  • Gilead Sciences, Inc.
  • Celgene Corporation (a subsidiary of Bristol-Myers Squibb Company)
  • Bayer AG
  • Biogen Inc.
  • Daiichi Sankyo Company, Limited
  • Astellas Pharma Inc.
  • Eisai Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

Historical Year 2019

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Oncology Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Oncology Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Oncology Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Oncology Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Oncology Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Oncology Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Oncology Market size was valued at USD 286.04 billion in 2019 and is poised to grow from USD 309.3 billion in 2023 to USD 581.25 billion by 2031, growing at a CAGR of 8.2% in the forecast period (2024-2031).

The oncology market is fragmented in nature. The prominent players operating in the market are constantly adopting various growth strategies in order to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D in order to supply industries with the most efficient and cost-effective solutions. 'Roche Holding AG', 'Novartis International AG', 'Bristol-Myers Squibb Company', 'Pfizer Inc.', 'Merck & Co., Inc.', 'AstraZeneca PLC', 'Johnson & Johnson', 'Sanofi S.A.', 'Takeda Pharmaceutical Company Limited', 'Amgen Inc.', 'AbbVie Inc.', 'Eli Lilly and Company', 'Gilead Sciences, Inc.', 'Celgene Corporation (a subsidiary of Bristol-Myers Squibb Company)', 'Bayer AG', 'Biogen Inc.', 'Daiichi Sankyo Company, Limited', 'Astellas Pharma Inc.', 'Eisai Co., Ltd.', 'Teva Pharmaceutical Industries Ltd.'

The oncology market growth is attributed to the rising prevalence of cancer across the globe. Cancer has become the second greatest cause of death in the world, trailing only cardiovascular disease. This is caused by factors such as cigarette use, changing dietary patterns, and an extended post-reproductive lifespan. Cancer, for example, is a growing burden, with the number of new cancer cases expected to rise from 18.1 million in 2018 to 29.4 million by 2040, according to the World Health Organization (WHO). As a result, the rising prevalence of cancer is predicted to drive demand for worldwide oncology cancer medications during the forecast period. Furthermore, increased cancer awareness among the people is expected to benefit the market in the approaching years.

The expansion of the oncology market is aided by the growing focus on R&D to increase adoption of advanced drug therapies. The goals of cancer treatment are to cure the disease, prolong survival, and improve quality of life. Immune cells are crucial in tumor growth. As a result, boosting immune responses to malignancies is an appealing therapeutic and preventative method. As a result, top market players are investing in immunotherapy research and development to treat various tumors. In March 2019, for example, FUJIFILM Corporation and the National Cancer Center Japan announced the start of a joint research effort for novel cancer immunotherapy employing a liposome formulation. Immunotherapy has a stronger market adoption due to its success in terms of efficient treatment, which results in better patient outcomes. As a result, this contributes to market growth.

In 2021, North America is expected to have the biggest share of the oncology market. The region's dominance is due to the increased incidence and prevalence of cancer in the United States, as well as new product introductions in the region. According to the National Cancer Institute, roughly 1.8 million people in the United States will be diagnosed with cancer in 2020. Europe, after North America, is expected to account for the second-largest share of the market. Because of the rising cancer burden, high-growth countries such as the United Kingdom, Germany, France, Italy, and Spain will contribute to the expansion of the European oncology market. Because of increased population awareness, the Asia Pacific oncology market is likely to grow at a quicker rate. The rising prevalence of cancer and rising healthcare costs will boost regional growth. Latin America, the Middle East, and Africa are projected to see sluggish development due to a lack of awareness and affordability of high-cost biologic medications.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Oncology Market

Product ID: SQSG35J2013

$5,300
BUY NOW GET FREE SAMPLE